Trials / Completed
CompletedNCT02908828
Calanus Oil Supplementation and Maximal Oxygen Uptake
Effect of Copepod Oil Supplementation (Calanus Finmarchicus) on Endurance and VO2max in Healthy Obese Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Copepod oil is extracted from the marine copepod Calanus finmarchicus, the dominant plankton species in the marine food web in the Norwegian Sea. Copepods constitute the largest renewable and harvestable resource in the Norwegian Sea and adjacent waters, and it is now developed knowledge and technology for sustainable harvesting of this "new" resource. The purpose of this study is to investigate whether Calanus copepod oil supplementation has an equivalent effect on maximal oxygen uptake in humans to that seen in experimental studies in mice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Calanus oil | |
| DIETARY_SUPPLEMENT | placebo dietary oil |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-09-19
- Completion
- 2017-09-19
- First posted
- 2016-09-21
- Last updated
- 2020-09-30
Locations
2 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT02908828. Inclusion in this directory is not an endorsement.